Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Trailblazing CEO Blake Schroeder leads company to strong Q2 numbers with 7.8M in net revenue

Trailblazing CEO Blake Schroeder leads company to strong Q2 numbers with 7.8M in net revenue

Medical Marijuana CEO Blake Schroeder joined Steve Darling from Proactive to share news the company, which was the first ever Cannabis company publicly traded in the US, has announced their 2nd quarter financial numbers. Schroeder telling Proactive the company saw 7.8 million in net revenue while generating a Gross profit for the period of 6 million. The company also saw Gross margins for the period were 76% which is a huge increase over the same period last year. Schroeder also shared some details about the company’s international operations and pharmaceutical initiatives

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK